Literature DB >> 20685053

Measurement of relative cerebral blood volume using BOLD contrast and mild hypoxic hypoxia.

Richard G Wise1, Kyle T S Pattinson, Daniel P Bulte, Richard Rogers, Irene Tracey, Paul M Matthews, Peter Jezzard.   

Abstract

Relative cerebral blood volume (CBV) was estimated using a mild hypoxic challenge in humans, combined with BOLD contrast gradient-echo imaging at 3 T. Subjects breathed 16% inspired oxygen, eliciting mild arterial desaturation. The fractional BOLD signal change induced by mild hypoxia is expected to be proportional to CBV under conditions in which there are negligible changes in cerebral perfusion. By comparing the regional BOLD signal changes arising with the transition between normoxia and mild hypoxia, we calculated CBV ratios of 1.5 ± 0.2 (mean ± S.D.) for cortical gray matter to white matter and 1.0 ± 0.3 for cortical gray matter to deep gray matter.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20685053     DOI: 10.1016/j.mri.2010.06.002

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  3 in total

1.  Dual echo vessel-encoded ASL for simultaneous BOLD and CBF reactivity assessment in patients with ischemic cerebrovascular disease.

Authors:  Carlos C Faraco; Megan K Strother; Lindsey M Dethrage; Lori Jordan; Robert Singer; Paul F Clemmons; Manus J Donahue
Journal:  Magn Reson Med       Date:  2014-04-22       Impact factor: 4.668

2.  Effects of Chronic Hypoxic Environment on Cognitive Function and Neuroimaging Measures in a High-Altitude Population.

Authors:  Ya Qing Zhang; Wen Juan Zhang; Jin Hao Liu; Wei Zhong Ji
Journal:  Front Aging Neurosci       Date:  2022-05-06       Impact factor: 5.702

3.  High-resolution structural and functional assessments of cerebral microvasculature using 3D Gas ΔR2*-mMRA.

Authors:  Chien-Hsiang Huang; Chiao-Chi V Chen; Tiing-Yee Siow; Sheng-Hsiou S Hsu; Yi-Hua Hsu; Fu-Shan Jaw; Chen Chang
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.